Marc Cummings - March, 2018

Share via email...

1551 Eastlake Ave. E
Suite 300
Seattle, WA 98102
United States
Phone: 206-321-4679
Filed: April 16, 2018 - 3:48 pm

Personal Expenses

Personal expenses reimbursed by employer.

No reimbursed personal expenses reported for March, 2018
Sum of all personal expenses not reimbursed by employer.

No non-reimbursed personal expenses reported for March, 2018

Compensation

Detailed compensation by employer.
EmployerAmount
Life Science Washington141.00
Payments to sub-contracted lobbyists.

No payments to sub-contracted lobbyists reported for March, 2018

Entertainment

Itemized entertainment expenses.
DateDescriptionPlaceCostType of OccasionParticipant ListingEmployer
Monday, March 26, 2018Annual Board ReceptionColumbia Tower - Seattle3240.25ReceptionCost - $2,196.44 + $1043.81(tax/gratuity) = $3240.25 Total Cost ALL LEGISLATORS INVITED Attendees: Alice Chen Accelerator Corporation Chad Cohen Adaptive Biotechnologies Gene DeFelice Adaptive Biotechnologies Nancy Hill Adaptive Biotechnologies Chad Robins Adaptive Biotechnologies Charles Sang Adaptive Biotechnologies Gustavo Mahler AGC Biologics Inc. Jane Gross Aptevo Therapeutics Inc. Randy Maddux Aptevo Therapeutics Inc. Tom Clement Aqueduct Critical Care, Inc. Homer Lane Benaroya Research Institute at Virginia Mason Margaret McCormick Benaroya Research Institute at Virginia Mason Virginia Emery Beta Hatch Charlotte Hubbert Bill & Melinda Gates Foundation Peter Frey BIO (Biotechnology Innovation Organization) Mike Ruhl BioMed Realty Trust Becky Bogard Bogard & Johnson Bill Brady Brady & Company Adrian Hobden CereSpir Rebecca Lovell City of Seattle, Office of Economic Development Sonya Erickson Cooley LLP Oren Lang-Furr Ernst & Young LLP Stephen Graham Fenwick & West LLP R. Hans Kemp Flinn Ferguson Corporate Real Estate Bob Mooney Flinn Ferguson Corporate Real Estate Denise Galloway Fred Hutch Katie Smolnycki Fred Hutch Matthew Trunnell Fred Hutch Stacia Rasmussen Greater Spokane Inc. Susan Ashe Health Sciences & Services Authority Jean Paul Tousignant Illumia Thomas Jung KBI Biopharma Thomas Jung II KBI Biopharma Candice Decaire Kilpatrick Townsend & Stockton LLP Mitchell Parrish Kinetiq Leslie Alexandre Life Science Washington Marc Cummings Life Science Washington Brian Dershowitz Life Science Washington Kathleen Goodfellow Life Science Washington Meg O'Conor Life Science Washington Chris Porter Life Science Washington Amanda Tran Life Science Washington Nate Miles Lilly Alex Dunne Locomotive Partners Tonya Peck Locomotive Partners Patricia Beckman LSW Institute Mike Gallatin Mavupharma William Waller Monitor Mask Inc. Francisco Velazquez NA Brad Gray NanoString Technologies, Inc. Ron Myers Nexgenia Jan Beck Novo Nordisk Research Center Seattle, Inc. Caitlin Cameron OtoNexus Medical Technologies, Inc. Jeff Chamberlain Pacific Biomarkers John Wecker Pacific Northwest Research Institute Erik Nilsson Pataigin Skye Gilbert PATH Lee Schindler Perkins Coie LLP Jennifer Olsen Resourceful HR Rod Oskouian Seattle Science Foundation Qing (Becky) Lin Seed IP Law Group LLP Stephen Rosenman Seed IP Law Group LLP Eric Larsen SiDx Gregory Sessler Spiration, Inc., dba Olympus Respiratory America Jary Krauser StratusG Consulting Neal Myrick Tableau Foundation Tim Boyd TSB Group Dena Morris Washington Global Health Alliance Representative Nicole Macri Washington State Legislature Representative Vandana Slatter Washington State Legislature Senator Joe Fain Washington State Senate Senator Reuven Carlyle Washington State Senate Kevin Murphy Washington State University Ken Roberts Washington State University John Roll Washington State University Life Science Washington
Non-itemized entertainment expenses.

No non-itemized entertainment expenses reported for March, 2018

Contributions

Reporting of all monetary and in-kind contributions made by the lobbyist or transmitted by the lobbyist on behalf of the lobbyist's client, PACs or other contributors.
Itemized contributions by employer.

No itemized contributions by employer reported for March, 2018
Itemized contributions by employer's PAC.

No itemized contributions by employer's PAC reported for March, 2018
Other itemized contributions.

No other itemized contributions reported for March, 2018
Non-itemized contributions by employer.

No non-itemized contributions by employer reported for March, 2018
Total of all other non-itemized contributions.

No other non-itemized contributions reported for March, 2018

PAC contribution activity

Reporting of PAC contribution activity for contributions not made by or transmitted by the lobbyist. This section only indicates that the lobbyist was aware of the contribution activity but did not take part and is not reporting any dollar amounts.
PAC contributions not transmitted by lobbyist.

No PAC contribution activity reported for March, 2018

Advertising

Itemized reporting of expenses for advertising, printing, informational literature.
Advertising.

No advertising expenses reported for March, 2018

Political ads

Itemized reporting of expenses for political ads, public relations, polling, telemarketing, etc.
Political ads.

No political advertising expenses reported for March, 2018

Other lobbying expenses

Payments by the Lobbyist for other lobbying expenses and services, including payments to subcontract lobbyists, expert witnesses and others retained to provide lobbying services or assistance in lobbying and payments for grass-roots lobbying campaigns.
Detailed expenses.

No other lobbying expenses reported for March, 2018

Lobbying activities

All subject areas lobbied for each employer and time spent lobbying.
Subject area(s) lobbied.
EmployerSubject Matter of Proposed LegislationIssue or bill numberPersons, Legislative committee or State Agency considering the matter
Life Science WashingtonFiscalLife Science Discovery FundHouse Technology & Economic Dev; Commerce; Life Science Discovery Fund
Percent of time spent lobbying the legislature.

100.00%

 Percent of time spent lobbying state agencies.

0.00%